Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 342 citing articles:

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Jerald Sadoff, Glenda Gray, An Vandebosch, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 23, pp. 2187-2201
Open Access | Times Cited: 2398
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
Jerald Sadoff, Mathieu Le Gars, Georgi Shukarev, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 19, pp. 1824-1835
Open Access | Times Cited: 1111
Viral targets for vaccines against COVID-19
Lianpan Dai, George F. Gao
Nature reviews. Immunology (2020) Vol. 21, Iss. 2, pp. 73-82
Open Access | Times Cited: 1065
Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis
Bryan A. Johnson, Xuping Xie, Adam L. Bailey, et al.
Nature (2021) Vol. 591, Iss. 7849, pp. 293-299
Open Access | Times Cited: 714
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
Manish Sadarangani, Arnaud Marchant, Tobias R. Kollmann
Nature reviews. Immunology (2021) Vol. 21, Iss. 8, pp. 475-484
Open Access | Times Cited: 546
Advances in COVID-19 mRNA vaccine development
Enyue Fang, Xiaohui Liu, Miao Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 416
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
Franz X. Heinz, Karin Stiasny
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 348
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
Galit Alter, Jingyou Yu, Jinyan Liu, et al.
Nature (2021) Vol. 596, Iss. 7871, pp. 268-272
Open Access | Times Cited: 321
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development
Yingzhu Li, Rumiana Tenchov, Jeffrey Smoot, et al.
ACS Central Science (2021) Vol. 7, Iss. 4, pp. 512-533
Open Access | Times Cited: 318
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
Kathryn E. Stephenson, Mathieu Le Gars, Jerald Sadoff, et al.
JAMA (2021) Vol. 325, Iss. 15, pp. 1535-1535
Open Access | Times Cited: 303
The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review
Ibrahim Mohammed, Areej Nauman, Pradipta Paul, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 298
Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
Samir Andrade Mendonça, Réka Lőrincz, Paul J. Rice-Boucher, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 253
Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
Karin Bok, Sandra Sitar, Barney S. Graham, et al.
Immunity (2021) Vol. 54, Iss. 8, pp. 1636-1651
Open Access | Times Cited: 238
Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis
Victoria Rotshild, Bruria Hirsh Raccah, Ian Miskin, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 223
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Daniel Martínez-Flores, Jesús Zepeda–Cervantes, Adolfo Cruz-Reséndiz, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 219
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S
Jerald Sadoff, Glenda Gray, An Vandebosch, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 9, pp. 847-860
Open Access | Times Cited: 203
Modelling optimal vaccination strategy for SARS-CoV-2 in the UK
Sam Moore, Edward M. Hill, Louise Dyson, et al.
PLoS Computational Biology (2021) Vol. 17, Iss. 5, pp. e1008849-e1008849
Open Access | Times Cited: 179
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
Annika Fendler, Elisabeth G.E. de Vries, Corine H. GeurtsvanKessel, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 385-401
Open Access | Times Cited: 179
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 178
A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice
Abigail E. Powell, Kaiming Zhang, Mrinmoy Sanyal, et al.
ACS Central Science (2021) Vol. 7, Iss. 1, pp. 183-199
Open Access | Times Cited: 171
The humoral response and antibodies against SARS-CoV-2 infection
Hai Qi, Bo Liu, Xinquan Wang, et al.
Nature Immunology (2022) Vol. 23, Iss. 7, pp. 1008-1020
Open Access | Times Cited: 151
HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors
Evan Tan, Cara Sze Hui Chin, Zhi Feng Sherman Lim, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 135
COVID‐19 vaccinations: The unknowns, challenges, and hopes
Kawthar Mohamed, Piotr Rzymski, Md Shahidul Islam, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1336-1349
Open Access | Times Cited: 125
Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals
Anthony T. Tan, Joey Ming Er Lim, Nina Le Bert, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 17
Open Access | Times Cited: 116
Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans
Per Johan Klasse, Douglas F. Nixon, John P. Moore
Science Advances (2021) Vol. 7, Iss. 12
Open Access | Times Cited: 114
Page 1 - Next Page

Scroll to top